March 9, 2019 / 12:11 AM / 15 days ago

J&J can't arbitrate Remicade antitrust case, drug wholesaler argues

A drug wholesaler is urging a federal appeals court to not send a lawsuit accusing Johnson & Johnson of seeking to suppress competition for its blockbuster rheumatoid arthritis drug Remicade to arbitration.

Rochester Drug Cooperative Inc told the 3rd U.S. Circuit Court of Appeals in a brief on Thursday that a federal judge in Philadelphia correctly determined its antitrust claims did not fall within the scope of an arbitration agreement it had signed with J&J.

To read the full story on Westlaw Practitioner Insights, click here:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below